Literature DB >> 22399794

Absence of consensus in diagnostic criteria for familial neurodegenerative diseases.

Susan Byrne1, Marwa Elamin, Peter Bede, Orla Hardiman.   

Abstract

BACKGROUND: A small proportion of cases seen in neurodegenerative conditions such as amyotrophic lateral sclerosis (ALS), Parkinson's disease and Alzheimer disease are familial. These familial cases are usually clinically indistinguishable from sporadic cases. Identifying familial cases is important both in terms of clinical guidance for family members and for gene discovery.
METHOD: Surveys assessing the definition of familial amyotrophic lateral sclerosis (FALS) were completed by clinicians with an interest in ALS.
RESULTS: 95 surveys were completed by respondents from 15 countries. A third of total respondents stated that they thought that neurologists were using the same definition for FALS (33.3%, 30). No consensus was achieved among clinicians when provided with five different definitions for FALS. However, the preferred definition was 'a patient with ALS with either a first or second degree relative also with ALS' (37.8%, 31).
CONCLUSION: There is no consensus on a standard definition for FALS among clinicians. It is likely that similar inconsistencies apply to other conditions, such as Parkinson's disease and Alzheimer disease, in which both familial and sporadic diseases occur. Inconsistent classification could hinder gene discovery.

Entities:  

Mesh:

Year:  2012        PMID: 22399794     DOI: 10.1136/jnnp-2011-301530

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  26 in total

Review 1.  Familial Amyotrophic Lateral Sclerosis.

Authors:  Kevin Boylan
Journal:  Neurol Clin       Date:  2015-09-08       Impact factor: 3.806

2.  Lack of consensus in ALS genetic testing practices and divergent views between ALS clinicians and patients.

Authors:  Holly Klepek; Haikady Nagaraja; Stephen A Goutman; Adam Quick; Stephen J Kolb; Jennifer Roggenbuck
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2019-04-01       Impact factor: 4.092

Review 3.  Clinical neurogenetics: amyotrophic lateral sclerosis.

Authors:  Matthew B Harms; Robert H Baloh
Journal:  Neurol Clin       Date:  2013-11       Impact factor: 3.806

4.  Complexities of Genetic Counseling for ALS: A Case of Two Siblings with Discordant Genetic Test Results.

Authors:  Paola Mandich; Vittorio Mantero; Simonetta Verdiani; Fabio Gotta; Claudia Caponnetto; Emilia Bellone; Giovanna Ferrandes; Paola Origone
Journal:  J Genet Couns       Date:  2015-04-07       Impact factor: 2.537

Review 5.  The imaging signature of C9orf72 hexanucleotide repeat expansions: implications for clinical trials and therapy development.

Authors:  Stacey Li Hi Shing; Mary Clare McKenna; We Fong Siah; Rangariroyashe H Chipika; Orla Hardiman; Peter Bede
Journal:  Brain Imaging Behav       Date:  2021-01-05       Impact factor: 3.978

6.  Use of Genetic Testing in Amyotrophic Lateral Sclerosis by Neurologists.

Authors:  Karissa C Arthur; Carly Doyle; Adriano Chiò; Bryan J Traynor
Journal:  JAMA Neurol       Date:  2017-01-01       Impact factor: 18.302

Review 7.  Gene discovery in amyotrophic lateral sclerosis: implications for clinical management.

Authors:  Ammar Al-Chalabi; Leonard H van den Berg; Jan Veldink
Journal:  Nat Rev Neurol       Date:  2016-12-16       Impact factor: 42.937

8.  Perspective: Don't keep it in the family.

Authors:  Ammar Al-Chalabi
Journal:  Nature       Date:  2017-10-18       Impact factor: 49.962

Review 9.  Current pathways for epidemiological research in amyotrophic lateral sclerosis.

Authors:  Pam Factor-Litvak; Ammar Al-Chalabi; Alberto Ascherio; Walter Bradley; Adriano Chío; Ralph Garruto; Orla Hardiman; Freya Kamel; Edward Kasarskis; Ann McKee; Imaharu Nakano; Lorene M Nelson; Andrew Eisen
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2013-05       Impact factor: 4.092

10.  Extensive genetics of ALS: a population-based study in Italy.

Authors:  Adriano Chiò; Andrea Calvo; Letizia Mazzini; Roberto Cantello; Gabriele Mora; Cristina Moglia; Lucia Corrado; Sandra D'Alfonso; Elisa Majounie; Alan Renton; Fabrizio Pisano; Irene Ossola; Maura Brunetti; Bryan J Traynor; Gabriella Restagno
Journal:  Neurology       Date:  2012-10-24       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.